Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR statement on allegations of bullying
The Institute of Cancer Research, London, is making the following statement regarding an investigation we have conducted into allegations of bullying by a staff member.
New computer prediction tool can forecast how cancer will resist drugs before they are given to patients
Sophisticated new computer software can be used to predict how cancers may respond to a new drug before it has ever been given to patients.
Drug combination gives ‘exciting’ results in ovarian and lung cancer in early trial
Combining a new targeted cancer drug with chemotherapy has shown promise in an early clinical trial, in patients with ovarian or lung cancer for whom all other treatments had failed.
Breast cancer vulnerability could point way to new target treatments
Researchers have identified a vulnerability in some breast cancer cells of a certain type – called triple negative breast cancer – that could be exploited by future targeted drugs.
Tumour 'diaries' track cancers' evolutionary history and predict the future
Scientists have developed a complex mathematical model that uses a snapshot of tumours’ genetic code to reach back in time, revealing its evolutionary history.
Discovery Club members hear about how philanthropy is making a difference to people with cancer
Members of the ICR’s Discovery Club, our high-level giving club of visionary supporters, learned about the difference that philanthropy is making to people with cancer at an event in the impressive surroundings of Two Temple Place, in Central London.
New prostate cancer blood test detects early treatment failure
A new prostate cancer blood test can detect early signs that cancer is evolving to become resistant to treatment, a new study has found.
Increased risk of myeloid blood cancers in relatives of patients
The largest ever study of its type is the first to definitively show an increased risk of blood cancers in relatives of patients.
New ‘super-resolution’ MRI could help plan radiotherapy treatment for lung cancer
Researchers have developed a new technique to create high-quality 3D movies of tissues in the body as they move, which could help doctors plan radiotherapy treatment for cancers including lung tumours.
Scientists uncover DNA ‘shield’ with crucial roles in normal cell division, the immune system and cancer
Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.
ICR part of major MedTech commercialisation programme
The ICR is taking part in a major new initiative to drive forward world-class university commercialisation across the country, and encourage collaboration between higher education institutions.
Tiny changes in prostate cancer blood test could spot early warning signs of treatment not working
A test that can detect trace levels of tumour cells in the blood could help spot early signs of treatment not working for men with advanced prostate cancer.